Hypoxia and Differentiation in Squamous Cell Carcinomas of the Uterine Cervix: Pimonidazole and Involucrin

Clinical Cancer Research

Volumn 9, Issue 13, 2003, Pages 4944-4952

  Azuma, Yoshihiro ^a   Chou, Shu Chuan ^a   Lininger, Ruth A ^a   Murphy, Brian J ^b   Varia, Mahesh A ^a   Raleigh, James A ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b SRI INTERNATIONAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1; HYPOXYPROBE 1; INVOLUCRIN; METALLOTHIONEIN; PIMONIDAZOLE; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1; TUMOR MARKER;

ARTICLE; CANCER GRADING; CELL DIFFERENTIATION; CELL PROLIFERATION; DRUG RECEPTOR BINDING; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN TISSUE; HYPOXIA; IMAGE ANALYSIS; PATTERN RECOGNITION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; SQUAMOUS CELL CARCINOMA; TRANSCRIPTION REGULATION; TUMOR DIFFERENTIATION; TUMOR LOCALIZATION; UTERINE CERVIX CARCINOMA;

ANOXIA; BIOPSY; CARCINOMA, SQUAMOUS CELL; CELL DIFFERENTIATION; CELL LINE, TUMOR; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; METALLOTHIONEIN; NITROIMIDAZOLES; OXYGEN; PROGNOSIS; PROTEIN PRECURSORS; RADIATION-SENSITIZING AGENTS; RNA, MESSENGER; TRANSCRIPTION, GENETIC; UTERINE CERVICAL NEOPLASMS;

EID: 0142250365     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Raleigh, J., Chou, S-C., Calkins-Adams, D., Ballenger, C., Novotny, D., and Varia, M. A clinical study of hypoxia and metallothionein protein expression in squamous cell carcinomas. Clin. Cancer Res., 6: 855-862, 2000.
2. Raleigh, J. A., Chou, S-C., Tables, L., Suchindran, S., Varia, M. A., and Horsman, M. R. Relationship of hypoxia to metallothionein expression in murine tumors. Int. J. Radiat. Oncol. Biol. Phys., 42: 727-730, 1998.
3. Murphy, B. J., Andrews, G. K., Bittel, D., Discher, D. J., McCue, J., Green, C. J., Yanovsky, M., Giaccia, A., Sutherland, R. M., Laderoute, K. R., and Webster, K. A. Activation of metallothionein gene expression by hypoxia involves metal response elements and metal transcription factor-1. Cancer Res., 59: 1315-1322, 1999.
4. Quaife, C. J., Findley, S. D., Erickson, J. C., Froelick, G. J., Kelly, E. J., Zambrowicz, B. P., and Palmiter, R. D. Induction of a new metallothionein (MT-IV) during differentiation of stratified squamous epithelia. Biochemistry, 33: 7250-7259, 1994.
5. Franko, A. J., Raleigh, J. A., Sutherland, R. G., and Soderlind, K. J. Metabolic binding of misonidazole to mouse tissues. Comparison between labels on the ring and side chain, and the production of tritiated water. Biochem. Pharmacol., 38: 665-670, 1989.
6. Varia, M. A., Calkins-Adams, D. P., Rinker, L. H., Kennedy, A. S., Novotny, D. B., Fowler, J., W. C., and Raleigh, J. A. Pimonidazole: a novel hypoxia marker for complementary study of tumor hypoxia and cell proliferation in cervical carcinoma. Gynecol. Oncol., 71: 270-277, 1998.
7. Kaanders, H. A. M., Wjjffels, K. I. E. M., Marres, H. A. M., Ljungkvist, A. S. E., Pop, L. A. M., van den Hoogen, F. J. A., de Wilde, P. C. M., Bussink, J., Raleigh, J. A., and van der Kogel, A. J. Patient selection for hypoxia-modifying treatments based on pimonidazole binding and tumor vascularity. Cancer Res., 62: 7066-7074, 2002.
8. Olive, P. L., Aquino-Parsons, C., MacPhail, S. H., Liao. S. Y., Raleigh, J. A., Lerman, M. I., and Stanbridge, E. J. Carbonic anhydrase 9 as an endogenous marker for hypoxic cells in cervical cancer. Cancer Res., 61: 8924-8929, 2001.
9. Crish, J. F., Bone, F., Banks, E. B., and Eckert, R. L. The human involucrin gene contains spatially distinct regulatory elements that regulate expression during early versus late epidermal differentiation. Oncogene. 21: 738-747, 2002.
10. Laderoute, K. R., Calaoagan, J. M., Gustafson-Brown, C., Knapp, A. M., Li, G. C., Mendonca, H. L., Ryan, H. E., Wang, Z., and Johnson, R. S. The response of c-jun/AP-1 to chronic hypoxia is hypoxia-inducible factor 1α dependent. Mol. Cell. Biol., 22: 2515-2523, 2002.
11. Arteel, G. E., Thurman, R. G., Yates, J. M., and Raleigh, J. A. Evidence that hypoxia markers detect oxygen gradients in liver: pimonidazole and retrograde perfusion of rat liver. Br. J. Cancer. 72: 889-895, 1995.
12. Allen, J. G., Dische, S., Lenox-Smith, I., Malcolm, S. L., and Saunders, M. I. The pharmacokinetics of a new radiosensitiser, Ro 03-8799 in humans. J. Clin. Pharmacol., 27: 483-489, 1984.
13. Saunders, M. I., Anderson, P. J., Bennett, M. H., Dische, S., Minchinton, A. I., and Stratford, M. R. L. The clinical testing of Ro 03-8799: pharmacokinetics, toxicology, tissue and tumor concentrations. Int. J. Radiat. Oncol. Biol. Phys., 10: 1759-1763, 1984.
14. Nordsmark, M., Loncaster, J., Chou, S. C., Havsteen, H., Lindegaard, J. C., Davidson, S. E., Varia, M., West, C., Hunter, R., Overgaard, J., and Raleigh, J. A. Invasive oxygen measurements and pimonidazole labeling in human cervix carcinoma. Int. J. Radiat. Oncol. Biol. Phys., 49: 581-586, 2001.
15. Wykoff, C. C., Beasley, N. J., Watson, P. H., Turner, K. J., Pastorek, J., Sibtain, A., Wilson, G. D., Turley, H., Talks, K. L., Maxwell, P. H., Pugh, C. W., Ratcliffe, P. J., and Harris, A. L. Hypoxia-inducible expression of tumor-associated carbonic anhydrases. Cancer Res., 60: 7075-7083, 2000.
16. Janssen, H. L., Haustermans, K. M., Sprong, D., Blommestijn, G., Hofland, I., Hoebers, F. J., Blijweert, E., Raleigh, J. A., Semenza, G. L., Varia, M. A., Balm, A. J., van Velthuysen, M. L., Delaere, P., Sciot, R., and Begg, A. C. HIF-1α, pimonidazole, and iododeoxyuridine to estimate hypoxia and perfusion in human head-and-neck tumors. Int. J. Radiat. Oncol. Biol. Phys., 54: 1537-1549, 2002.
17. Airley, R. E., Loncaster, J., Raleigh, J. A., Harris, A. L., Davidson, S. E., Hunter, R. D., West, C. M., and Stratford, I. J. GLUT-1 and CAIX as intrinsic markers of hypoxia in carcinoma of the cervix: relationship to pimonidazole binding. Int. J. Cancer, 104: 85-91, 2003.
18. Murphy, B. J., Laderoute, K. R., Chin, R. J., and Sutherland, R. M. Metallothionein IIA is up-regulated by hypoxia in human A431 squamous carcinoma cells. Cancer Res., 54: 5808-5810, 1994.
19. Raleigh, J. A., Chou, S-C., Arteel, G. E., and Horsman, M. R. Comparisons among pimonidazole binding, oxygen electrode measurements and radiation response in C3H mouse tumors. Radiat. Res., 151: 580-589, 1999.
20. Raleigh, J. A., Chou, S. C., Bono, E. L., Thrall, D. E., and Varia, M. A. Semiquantitative immunohistochemical analysis for hypoxia in human tumors. Int. J. Radiat. Oncol. Biol. Phys., 49: 569-574, 2001.
21. Viac, J., Palacio, S., Schmitt, D., and Claudy, A. Expression of vascular endothelial growth factor in normal epidermis, epithelial tumors and cultured keratinocytes. Arch. Dermatol. Res., 289: 158-163, 1997.
22. Raleigh, J. A., Calkins-Adams, D. P., Rinker, L. H., Ballenger, C. A., Weissler, M. C., Fowler, W. C., Jr., Novotny, D. B., and Varia, M. A. Hypoxia and vascular endothelial growth factor expression in human squamous cell carcinomas using pimonidazole as a hypoxia marker. Cancer Res., 58: 3765-3768, 1998.
23. Serra, V., Ramirez, A. A., Lara, C., Marzo, C., Castells, A., and Bonilla-Musoles, F. Distribution of involucrin in normal and pathological human uterine cervix. Gynecol. Oncol., 36: 34-42, 1990.
24. Leith, J. T., and Michelson, S. Secretion rates and levels of vascular endothelial growth factor in clone A or HCT-8 human colon tumour cells as a function of oxygen concentration. Cell Prolif., 28: 415-430, 1995.
25. Chiarotto, J. A., and Hill, R. P. A quantitative analysis of the reduction in oxygen levels required to induce up-regulation of vascular endothelial growth factor (VEGF) mRNA in cervical cancer cell lines. Br. J. Cancer, 80: 1518-1524, 1999.
26. Aebersold, D. M., Burri, P., Beer, K. T., Laissue, J., Djonov, V., Greiner, R. H., and Semenza, G. L. Expression of hypoxia-inducible factor-1α: a novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer. Cancer Res., 61: 2911-2916, 2001.
27. Haugland, H. K., Vukovic, V., Pintilie, M., Fyles, A. W., Milosevic, M., Hill, R. P., and Hedley, D. W. Expression of hypoxia-inducible factor-1α in cervical carcinomas: correlation with tumor oxygenation. Int. J. Radiat. Oncol. Biol. Phys., 53: 854-861, 2002.
28. Wiesener, M. S., Munchenhagen, P. M., Berger, I., Morgan, N. V., Roigas, J., Schwiertz, A., Jurgensen, J. S., Gruber, G., Maxwell, P. H., Loning, S. A., Frei, U., Maher, E. R., Grone, H. J., and Eckardt, K. U. Constitutive activation of hypoxia-inducible genes related to overexpression of hypoxia-inducible factor-1α in clear cell renal carcinomas. Cancer Res., 61: 5215-5222, 2001.
29. Sahai, A., Mei, C., Zavosh, A., and Tannen, R. L. Chronic hypoxia induces LLC-PK1 cell proliferation and dedifferentiation by the activation of protein kinase C. Am. J. Physiol., 272: F809-F815, 1997.
30. Alsat, E., Wyplosz, P., Malassine, A., Guibourdenche, J., Porquet, D., Nessmann, C., and Evain-Brion, D. Hypoxia impairs cell fusion and differentiation process in human cytotrophoblast. J. Cell. Physiol., 168: 346-353, 1996.
31. Auersperg, N., Kruk, P. A., MacLaren, I. A., Watt, F. M., and Mydral, S. E. Heterogeneous expression of keratin, involucrin, and extracellular matrix among subpopulations of a poorly differentiated human cervical carcinoma: possible relationships to patterns of invasion. Cancer Res., 49: 3007-3014, 1989.
32. Hallows, K. R., Bliven, S. F., and Leith, J. T. Effects of the differentiating agents sodium butyrate and N-methylformamide on the oxygen enhancement ratio of human colon tumor cells. Radiat. Res., 113: 191-198, 1988.
33. Wheeler, K. T., and Wierowski, J. V. DNA accessibility: a determinant of mammalian cell differentiation? Radiat. Res., 93: 312-318, 1983.
34. Ansink, A., Mooi, W. J., van Doornewaard, G., van Tinteren, H., Heintz, A. P. M., and Ivanyi, D. Cytoskeleton subtypes and involucrin in squamous cell carcinoma of the vulva. Cancer (Phila.), 76: 638-643, 1995.
35. Wentz, W. B., and Lewis, G. C. Analytical study of the cells in cervical squamous cell cancer. Obstet. Gynecol., 26: 228-232, 1965.
36. Okada, S., Tsuda, H., Ohmi, K., Kasamatsu, T., Yamada, T., Tsunematsu, R., Sumi, M., Tokuuye, K., Yoshikawa, H., and Hirohashi, S. Immature glandular features in squamous cell carcinoma of the uterine cervix as an independent indicator of resistance to radiotherapy. Int. J. Gynecol. Cancer, 12: 277-285, 2002.
37. Hockel, M., Schlenger, K., Aral, B., Mitze, M., Schaffer, U., and Vaupel, P. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res., 56: 4509-4515, 1996.
38. Fyles, A., Milosevic, M., Hedley, D., Pintilie, M., Levin, W., Manchul, L., and Hill, R. P. Tumor hypoxia has independent predictor impact only in patients with node-negative cervix cancer. J. Clin. Oncol., 20: 680-687, 2002.